2019 ACR/ARP Annual Meeting

November 8-13, 2019. Atlanta, GA.

View by Number View by Title View Sessions

View by Date

Sunday, November 10, 2019

9:00AM-11:00AM: Antiphospholipid Syndrome Poster

9:00AM-11:00AM: Cytokines & Cell Trafficking Poster

9:00AM-11:00AM: Education Poster

9:00AM-11:00AM: Education/Community Programs Poster – ARP

9:00AM-11:00AM: Epidemiology & Public Health Poster I: RA

9:00AM-11:00AM: Epidemiology & Public Health Poster I: RA – ARP

9:00AM-11:00AM: Fibromyalgia & Other Clinical Pain Syndromes Poster

9:00AM-11:00AM: Health Services Research Poster I – ACR/ARP

9:00AM-11:00AM: Imaging Of Rheumatic Diseases Poster I

9:00AM-11:00AM: Innate Immunity Poster

9:00AM-11:00AM: Measures Of Healthcare Quality Poster I: Testing, Screening, & Treating

9:00AM-11:00AM: Metabolic & Crystal Arthropathies Poster I: Clinical

9:00AM-11:00AM: Miscellaneous Rheumatic & Inflammatory Disease Poster I: Fibroinflammatory & Granulomatous Disorders & Therapies

9:00AM-11:00AM: Muscle Biology, Myositis & Myopathies Poster I

9:00AM-11:00AM: Patient Outcomes, Preferences, & Attitudes Poster I: Patient Reported Outcomes

9:00AM-11:00AM: Pediatric Rheumatology – ePoster I: Basic Science, Biomarkers, & Sclerodermic Fever

9:00AM-11:00AM: Pediatric Rheumatology – ePoster I: Basic Science, Biomarkers, & Sclerodermic Fever – ARP

9:00AM-11:00AM: RA – Diagnosis, Manifestations, & Outcomes Poster I: Risk Factors, Predictors, & Prognosis

9:00AM-11:00AM: RA – Etiology & Pathogenesis Poster I

9:00AM-11:00AM: RA – Treatments Poster I: Novel Treatments

9:00AM-11:00AM: SLE – Animal Models Poster

9:00AM-11:00AM: SLE – Clinical Poster I: Epidemiology & Pathogenesis

9:00AM-11:00AM: SLE – Clinical Poster I: Epidemiology & Pathogenesis – ARP

9:00AM-11:00AM: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Axial Spondyloarthritis, Clinical Features

9:00AM-11:00AM: Systemic Sclerosis & Related Disorders – Clinical Poster I

9:00AM-11:00AM: T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

9:00AM-11:00AM: Vasculitis – Non-ANCA-Associated & Related Disorders Poster I: Takayasu's Arteritis & Polymyalgia Rheumatica

11:00AM-12:30PM: 3S032: Plenary I (805–809)

11:30AM-1:30PM: Patient Perspectives Poster Session

2:30PM-4:00PM: 3S074: Epidemiology & Public Health I: Risk Factors & Outcomes for Rheumatic Diseases (821–826)

2:30PM-4:00PM: 3S075: Fibromyalgia & Other Clinical Pain Syndromes (827–832)

2:30PM-4:00PM: 3S076: Patient Outcomes, Preferences, & Attitudes I: Patient Reported Outcomes (833–838)

2:30PM-4:00PM: 3S077: Pediatric Rheumatology – Basic Science (810–814)

2:30PM-4:00PM: 3S078: RA – Diagnosis, Manifestations, & Outcomes I: Pulmonary & Other Comorbidities (839–844)

2:30PM-4:00PM: 3S079: RA – Etiology & Pathogenesis I (815–820)

2:30PM-4:00PM: 3S080: RA – Treatments I: Safety and Outcomes (845–850)

2:30PM-4:00PM: 3S081: SLE – Clinical I: Clinical Trials (857–862)

2:30PM-4:00PM: 3S083: Spondyloarthritis Including Psoriatic Arthritis – Clinical I: Imaging in Axial Spondyloarthritis & Psoriatic Arthritis (851–856)

2:30PM-4:00PM: 3S084: Systemic Sclerosis & Related Disorder – Clinical I: Therapeutics & Outcomes (863–868)

2:30PM-4:00PM: 3S085: Vasculitis – ANCA-Associated I (869–874)

2:30PM-4:00PM: 3S092: New Approaches to Old Diseases (875–879)

4:30PM-6:00PM: 3S089: Health Services Research I: Clinical Perspectives (951–956)

4:30PM-6:00PM: 3S100: B Cell Biology & Targets in Autoimmune & Inflammatory Disease (880–885)

4:30PM-6:00PM: 3S101: Epidemiology & Public Health II: SLE (892–897)

4:30PM-6:00PM: 3S102: Metabolic & Crystal Arthropathies I: Clinical (898–902)

4:30PM-6:00PM: 3S104: Miscellaneous Rheumatic & Inflammatory Disease I: Expanding the Spectrum of Clinical Features in Rheumatological Disorders (903–908)

4:30PM-6:00PM: 3S105: Osteoarthritis & Joint Biology – Basic Science (886–891)

4:30PM-6:00PM: 3S106: Osteoarthritis – Clinical I: Innovations (909–914)

4:30PM-6:00PM: 3S107: Pediatric Rheumatology – Clinical I: Systemic JIA (915–920)

4:30PM-6:00PM: 3S108: RA – Diagnosis, Manifestations, & Outcomes II: Cardiovascular Comorbidities (921–926)

4:30PM-6:00PM: 3S109: RA – Treatments II: Novel Treatments for RA (927–932)

4:30PM-6:00PM: 3S110: SLE – Clinical III: Clinical Trials II (939–944)

4:30PM-6:00PM: 3S111: Spondyloarthritis Including Psoriatic Arthritis – Clinical II: Axial Spondyloarthritis Treatment (933–938)

4:30PM-6:00PM: 3S112: Vasculitis – Non-ANCA-Associated & Related Disorders I: Miscellaneous Disorders (945–950)

Monday, November 11, 2019

9:00AM-11:00AM: B Cell Biology & Targets In Autoimmune & Inflammatory Disease Poster

9:00AM-11:00AM: Epidemiology & Public Health Poster II: Spondyloarthritis & Connective Tissue Disease

9:00AM-11:00AM: Health Services Research Poster II – ACR/ARP

9:00AM-11:00AM: Healthcare Disparities In Rheumatology Poster

9:00AM-11:00AM: Imaging Of Rheumatic Diseases Poster II

9:00AM-11:00AM: Measures Of Healthcare Quality Poster II: Improving Care

9:00AM-11:00AM: Metabolic & Crystal Arthropathies Poster II: Clinical Trials & Basic Science

9:00AM-11:00AM: Miscellaneous Rheumatic & Inflammatory Disease Poster II: Autoinflammation Related Diseases & Therapies

9:00AM-11:00AM: Muscle Biology, Myositis & Myopathies Poster II

9:00AM-11:00AM: Osteoarthritis – Clinical Poster I

9:00AM-11:00AM: Pediatric Rheumatology – ePoster II: SLE, Juvenile Dermatomyositis, & Scleroderma

9:00AM-11:00AM: Pediatric Rheumatology – ePoster II: SLE, Juvenile Dermatomyositis, & Scleroderma – ARP

9:00AM-11:00AM: RA – Animal Models Poster

9:00AM-11:00AM: RA – Diagnosis, Manifestations, & Outcomes Poster II: Treatments, Outcomes, & Measures

9:00AM-11:00AM: RA – Diagnosis, Manifestations, & Outcomes Poster II: Treatments, Outcomes, & Measures – ARP

9:00AM-11:00AM: RA – Treatments Poster II: Established Treatments

9:00AM-11:00AM: Sjögrenʼs Syndrome – Basic & Clinical Science Poster II

9:00AM-11:00AM: SLE – Clinical Poster II: Comorbidities

9:00AM-11:00AM: SLE – Etiology & Pathogenesis Poster I

9:00AM-11:00AM: Spondyloarthritis Including Psoriatic Arthritis – Basic Science Poster

9:00AM-11:00AM: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster II: Treatment of Axial Spondyloarthritis & Psoriatic Arthritis

9:00AM-11:00AM: Systemic Sclerosis & Related Disorders – Basic Science Poster

9:00AM-11:00AM: Systemic Sclerosis & Related Disorders – Clinical Poster II

9:00AM-11:00AM: Vasculitis – ANCA-Associated Poster II

9:00AM-11:00AM: Vasculitis – Non-ANCA-Associated & Related Disorders Poster III: Behçet’s Disease & Other Vasculitides

11:00AM-12:30PM: 4M046: Plenary II (1758–1763)

2:30PM-4:00PM: 3S082: SLE – Clinical II: Flares & Morbidity of SLE (1824–1829)

2:30PM-4:00PM: 4M087: Antiphospholipid Syndrome (1788–1793)

2:30PM-4:00PM: 4M088: Cytokines & Cell Trafficking (1764–1769)

2:30PM-4:00PM: 4M089: Education (1794–1799)

2:30PM-4:00PM: 4M090: Infection-Related Rheumatic Disease (1800–1805)

2:30PM-4:00PM: 4M091: Miscellaneous Rheumatic & Inflammatory Disease II: Checkpoint Inhibitors-Induced & Other Rheumatic Conditions (1806–1811)

2:30PM-4:00PM: 4M092: Pediatric Rheumatology – Clinical II: JIA (1812–1817)

2:30PM-4:00PM: 4M093: RA – Animal Models (1770–1775)

2:30PM-4:00PM: 4M094: SLE – Animal Models (1782–1787)

2:30PM-4:00PM: 4M095: Spondyloarthritis Including Psoriatic Arthritis – Basic Science (1776–1781)

2:30PM-4:00PM: 4M096: Spondyloarthritis Including Psoriatic Arthritis – Clinical III: Miscellaneous (1818–1823)

2:30PM-4:00PM: 4M097: Systemic Sclerosis & Related Disorder – Clinical II: Cardiopulmonary Involvement (1830–1835)

2:30PM-4:00PM: 4M098: Vasculitis – Non-ANCA-Associated & Related Disorders II: Large Vessel Vasculitis Treatment (1836–1841)

2:30PM-4:00PM: 4M127: Pain, Anxiety, & Depression (1842–1847)

4:30PM-6:00PM: 4M110: Healthcare Disparities in Rheumatology (1848–1853)

4:30PM-6:00PM: 4M111: Imaging of Rheumatic Diseases I (1854–1859)

4:30PM-6:00PM: 4M112: Measures of Healthcare Quality I: Digital Health Technologies – Tool for Improvement (1860–1865)

4:30PM-6:00PM: 4M113: Muscle Biology, Myositis & Myopathies I (1866–1871)

4:30PM-6:00PM: 4M114: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science (1872–1877)

4:30PM-6:00PM: 4M115: Pain Mechanisms – Basic & Clinical Science (1878–1883)

4:30PM-6:00PM: 4M116: RA – Diagnosis, Manifestations, & Outcomes III: Diagnosis & Prognosis (1884–1889)

4:30PM-6:00PM: 4M117: RA – Treatments III: Cardiovascular Disease & Readmissions (1890–1895)

4:30PM-6:00PM: 4M118: Reproductive Issues in Rheumatic Disorders (1896–1901)

4:30PM-6:00PM: 4M119: Sjögrenʼs Syndrome – Basic & Clinical Science (1902–1907)

4:30PM-6:00PM: 4M120: SLE – Clinical IV: Lupus Nephritis (1914–1919)

4:30PM-6:00PM: 4M121: Spondyloarthritis Including Psoriatic Arthritis – Clinical IV: Axial Spondyloarthritis Translational Research (1908–1913)

4:30PM-6:00PM: 4M125: Pediatric Rheumatology: Outcomes & Quality of Life (1920–1925)

Tuesday, November 12, 2019

9:00AM-11:00AM: Epidemiology & Public Health Poster III: OA, Gout, & Other Diseases

9:00AM-11:00AM: Epidemiology & Public Health Poster III: OA, Gout, & Other Diseases – ARP

9:00AM-11:00AM: Genetics, Genomics & Proteomics Poster

9:00AM-11:00AM: Infection-Related Rheumatic Disease Poster

9:00AM-11:00AM: Late-Breaking Abstracts ePoster

9:00AM-11:00AM: Miscellanous Rheumatic & Inflammatory Disease Poster III: Autoimmune Conditions and Therapies

9:00AM-11:00AM: Orthopedics, Low Back Pain, & Rehabilitation Poster – ACR/ARP

9:00AM-11:00AM: Osteoarthritis – Clinical Poster II

9:00AM-11:00AM: Osteoarthritis & Joint Biology – Basic Science Poster

9:00AM-11:00AM: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster

9:00AM-11:00AM: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster – ARP

9:00AM-11:00AM: Patient Outcomes, Preferences, & Attitudes Poster II: Patient Preferences, Beliefs, & Experiences

9:00AM-11:00AM: Patient Outcomes, Preferences, & Attitudes Poster II: Patient Preferences, Beliefs, & Experiences – ARP

9:00AM-11:00AM: Pediatric Rheumatology – ePoster III: Systemic JIA, Fever, & Vasculitis

9:00AM-11:00AM: Pediatric Rheumatology – ePoster III: Systemic JIA, Fever, & Vasculitis – ARP

9:00AM-11:00AM: Psychology/Social Science Poster – ARP

9:00AM-11:00AM: RA – Diagnosis, Manifestations, & Outcomes Poster III: Comorbidities

9:00AM-11:00AM: RA – Etiology & Pathogenesis Poster II

9:00AM-11:00AM: RA – Treatments Poster III: Safety and Outcomes

9:00AM-11:00AM: RA – Treatments Poster III: Safety and Outcomes – ARP

9:00AM-11:00AM: Reproductive Issues In Rheumatic Disorders Poster

9:00AM-11:00AM: Research Methodology Poster – ARP

9:00AM-11:00AM: Sjögrenʼs Syndrome – Basic & Clinical Science Poster I

9:00AM-11:00AM: SLE – Clinical Poster III: Treatment

9:00AM-11:00AM: SLE – Etiology & Pathogenesis Poster II

9:00AM-11:00AM: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster III: Psoriatic Arthritis, Clinical Features

9:00AM-11:00AM: Systemic Sclerosis & Related Disorders – Clinical Poster III

9:00AM-11:00AM: Vasculitis – ANCA-Associated Poster I

9:00AM-11:00AM: Vasculitis – Non-ANCA-Associated & Related Disorders Poster III: Giant Cell Arteritis

11:00AM-12:30PM: 5T047: Plenary III (2727–2732)

2:30PM-4:00PM: 5T087: Edmond L. Dubois, MD Memorial Lecture: SLE – Basic Science (2733–2737)

2:30PM-4:00PM: 5T088: Genetics, Genomics & Proteomics (2738–2743)

2:30PM-4:00PM: 5T089: Imaging of Rheumatic Diseases II (2750–2755)

2:30PM-4:00PM: 5T090: Osteoarthritis – Clinical II: Novel Therapies (2756–2761)

2:30PM-4:00PM: 5T091: Patient Outcomes, Preferences, & Attitudes II: Patient Preferences, Beliefs, & Experiences (2762–2767)

2:30PM-4:00PM: 5T092: RA – Treatments IV: Novel Therapy & Predicting Response (2768–2773)

2:30PM-4:00PM: 5T093: SLE – Clinical V: Emerging Knowledge of Current Treatments (2780–2785)

2:30PM-4:00PM: 5T094: Spondyloarthritis Including Psoriatic Arthritis – Clinical V: Axial Spondyloarthritis Clinical Studies (2774–2779)

2:30PM-4:00PM: 5T095: Systemic Sclerosis & Related Disorder – Basic Science (2744–2749)

2:30PM-4:00PM: 5T096: Vasculitis – ANCA-Associated II (2786–2791)

2:30PM-4:00PM: 5T098: Orthopedics, Low Back Pain & Rehabilitation (2798–2803)

2:30PM-4:00PM: 5T101: Clinical Aspects & Outcomes Research (2792–2797)

4:00PM-6:00PM: 5T132: Late-Breaking Abstracts

4:30PM-6:00PM: 5T109: Epidemiology & Public Health III: RA (2822–2827)

4:30PM-6:00PM: 5T110: Innate Immunity (2804–2809)

4:30PM-6:00PM: 5T111: Measures of Healthcare Quality II: Quality Improvement in Rheumatology – Still Getting Better (2828–2833)

4:30PM-6:00PM: 5T112: Metabolic & Crystal Arthropathies II: Genetics & Physiology (2834–2839)

4:30PM-6:00PM: 5T113: Muscle Biology, Myositis & Myopathies II (2840–2845)

4:30PM-6:00PM: 5T114: RA – Diagnosis, Manifestations, & Outcomes IV: Outcomes (2846–2851)

4:30PM-6:00PM: 5T115: SLE – Etiology & Pathogenesis I: Signaling Pathways (2810–2815)

4:30PM-6:00PM: 5T116: Spondyloarthritis Including Psoriatic Arthritis – Clinical VI: Psoriatic Arthritis Clinical Studies (2852–2857)

4:30PM-6:00PM: 5T117: T Cell Biology & Targets in Autoimmune & Inflammatory Disease (2816–2821)

Wednesday, November 13, 2019

9:00AM-10:30AM: 6W010: Pediatric Rheumatology – Clinical III: Juvenile SLE & Dermatomyositis (2864–2869)

9:00AM-10:30AM: 6W011: RA – Diagnosis, Manifestations, & Outcomes V: Treatment (2870–2875)

9:00AM-10:30AM: 6W012: RA – Etiology & Pathogenesis II (2858–2863)

9:00AM-10:30AM: 6W013: SLE – Clinical VI: Epidemiology, Diagnosis, & Outcomes (2882–2887)

9:00AM-10:30AM: 6W014: Spondyloarthritis Including Psoriatic Arthritis – Clinical VII: Psoriatic Arthritis Treatment (2876–2881)

9:00AM-10:30AM: 6W017: Health Services Research II: Health Economics (2888–2893)

11:00AM-12:30PM: 6W020: Miscellaneous Rheumatic & Inflammatory Disease III: Novel Therapies (2900–2905)

11:00AM-12:30PM: 6W021: RA – Treatments V: Switching & Tapering RA Medications (2906–2911)

11:00AM-12:30PM: 6W022: SLE – Etiology & Pathogenesis II (2894–2899)

11:00AM-12:30PM: 6W023: Systemic Sclerosis & Related Disorder – Clinical III: Predictors of Outcome (2912–2917)

11:00AM-12:30PM: 6W024: Vasculitis – Non-ANCA-Associated & Related Disorders III: Large Vessel Vasculitis Pathogenesis & Imaging (2918–2923)

11:00AM-12:30PM: 6W026: Epidemiology & Public Health (2924–2929)